Danielle M. Richman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Danielle M. Richman has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Carol B. Benson
Brigham and Women’s Hospital and Harvard Medical School
2 shared publications - Mary C. Frates
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
2 shared publications Ari J. Wassner
From the Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (D.M.R., C.B.B., P.M.D., E.A., M.C.F.); and Thyroid Program, Division of Endocrinology, Boston Children's Hospital, Boston, Mass (A.J.W., C.E.C., J.R.S.).
1 shared publicationCharles S. Fuchs
Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, MA, 02115, USA
1 shared publicationChristine E. Cherella
From the Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (D.M.R., C.B.B., P.M.D., E.A., M.C.F.); and Thyroid Program, Division of Endocrinology, Boston Children's Hospital, Boston, Mass (A.J.W., C.E.C., J.R.S.).
1 shared publicationElizabeth Asch
From the Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (D.M.R., C.B.B., P.M.D., E.A., M.C.F.); and Thyroid Program, Division of Endocrinology, Boston Children's Hospital, Boston, Mass (A.J.W., C.E.C., J.R.S.).
1 shared publication
Latest Publications
- 8 October 2026
- Published by Wiley in Journal of Ultrasound in Medicine
The Enlarged Fetal Thyroid: Sonographic and Clinical Findings
Retrospective review of our OB ultrasound database identified 17 fetuses with enlarged thyroid. Fourteen had a maternal risk factor, most commonly current or prior Graves' thyroiditis. In addition to the enlarged thyroid, abnormalities were identified in 6/17 (35.3%) fetuses. Treatment included adjusting the dose of propylthiouracil, methimazole, or levo‐thyroxine, intraamniotic thyroxine, or nothing. Follow‐up showed stable fetal thyroid size in 9 and decreased size in 5. Imagers should be aware that fetal goiter can result from maternal hyper‐ or hypothyroidism. Careful assessment and monitoring of mother and fetus are needed to determine the appropriate cause and treatment of fetal goiter.
- 8 October 2026
- Published by Wiley in Journal of Ultrasound in Medicine
The Enlarged Fetal Thyroid: Sonographic and Clinical Findings
Retrospective review of our OB ultrasound database identified 17 fetuses with enlarged thyroid. Fourteen had a maternal risk factor, most commonly current or prior Graves' thyroiditis. In addition to the enlarged thyroid, abnormalities were identified in 6/17 (35.3%) fetuses. Treatment included adjusting the dose of propylthiouracil, methimazole, or levo‐thyroxine, intraamniotic thyroxine, or nothing. Follow‐up showed stable fetal thyroid size in 9 and decreased size in 5. Imagers should be aware that fetal goiter can result from maternal hyper‐ or hypothyroidism. Careful assessment and monitoring of mother and fetus are needed to determine the appropriate cause and treatment of fetal goiter.
- 1 November 2020
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 58 (6) , 1033-1039
Ultrasound of the Normal Thyroid with Technical Pearls and Pitfalls
- 1 November 2020
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 58 (6) , 1033-1039
Ultrasound of the Normal Thyroid with Technical Pearls and Pitfalls
- 1 February 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 294 (2) , 415-420
Assessment of American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) for Pediatric Thyroid Nodules
The current American College of Radiology Thyroid Imaging Reporting and Data System criteria are inadequate for management of nodules in the pediatric population, because a high percentage (22.1%) ... Background The American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) is a recognized tool for management of thyroid nodules in adults but has not been validated in...
- 1 February 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 294 (2) , 415-420
Assessment of American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) for Pediatric Thyroid Nodules
The current American College of Radiology Thyroid Imaging Reporting and Data System criteria are inadequate for management of nodules in the pediatric population, because a high percentage (22.1%) ... Background The American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) is a recognized tool for management of thyroid nodules in adults but has not been validated in...
- 19 September 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 42 (1) , 124-140
Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms
Despite advances in molecular biology, imaging, and treatment, gastric neoplasms remain a significant cause of morbidity and mortality; gastric adenocarcinoma is the fifth most common malignancy and third most common cause of death worldwide (Brenner et al., Methods Mol Biol 472:467–477, 2009; Howson et al. Epidemiol Rev 8:1–27, 1986; Roder, Gastric Cancer 5(Suppl 1):5–11, 2002; Ferlay et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, 2013). Because of both the frequency at which malignant gastric tumors occur as well as the worldwide impact, gastric neoplasms remain important lesions to identify and characterize on all imaging modalities. Despite the varied histologies and behaviors of these neoplasms, many have similar imaging features. Nonetheless, the treatment, management, and prognosis of gastric neoplasms vary by pathology, so it is essential for the radiologist to make every effort to differentiate between these lesions and raise the less common entities as differential diagnostic considerations when appropriate.
- 19 September 2016
- Published by Springer Nature in Abdominal Radiology
- Vol. 42 (1) , 124-140
Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms
Despite advances in molecular biology, imaging, and treatment, gastric neoplasms remain a significant cause of morbidity and mortality; gastric adenocarcinoma is the fifth most common malignancy and third most common cause of death worldwide (Brenner et al., Methods Mol Biol 472:467–477, 2009; Howson et al. Epidemiol Rev 8:1–27, 1986; Roder, Gastric Cancer 5(Suppl 1):5–11, 2002; Ferlay et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, 2013). Because of both the frequency at which malignant gastric tumors occur as well as the worldwide impact, gastric neoplasms remain important lesions to identify and characterize on all imaging modalities. Despite the varied histologies and behaviors of these neoplasms, many have similar imaging features. Nonetheless, the treatment, management, and prognosis of gastric neoplasms vary by pathology, so it is essential for the radiologist to make every effort to differentiate between these lesions and raise the less common entities as differential diagnostic considerations when appropriate.
- Open Access
- 27 February 2015
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 5, 13
Malignant Tenosynovial Giant Cell Tumor of the Leg: A Radiologic-Pathologic Correlation and Review of the Literature
Malignant tenosynovial giant cell tumor (TGCT) is a rare clinical entity that can arise as a recurrent lesion or can co-exist with a benign TGCT lesion. Malignant TGCT most commonly arises in the lower extremity and tends to be clinically aggressive, with most patients developing recurrent lesions or dying. Much of the literature describes the histopathologic features and classifies this broad group of tumors, with little description of the imaging characteristics of this disease. We present the multimodality appearance of a case of malignant diffuse-type TGCT that recurred 2 months after resection with subsequent rapid clinical progression.
- 27 February 2015
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 5, 13
Open AccessMalignant Tenosynovial Giant Cell Tumor of the Leg: A Radiologic-Pathologic Correlation and Review of the Literature
Malignant tenosynovial giant cell tumor (TGCT) is a rare clinical entity that can arise as a recurrent lesion or can co-exist with a benign TGCT lesion. Malignant TGCT most commonly arises in the lower extremity and tends to be clinically aggressive, with most patients developing recurrent lesions or dying. Much of the literature describes the histopathologic features and classifies this broad group of tumors, with little description of the imaging characteristics of this disease. We present the multimodality appearance of a case of malignant diffuse-type TGCT that recurred 2 months after resection with subsequent rapid clinical progression.